{"id":"https://openalex.org/W2914138564","doi":"https://doi.org/10.1080/14712598.2019.1575358","title":"Complement inhibition as a therapeutic strategy in retinal disorders","display_name":"Complement inhibition as a therapeutic strategy in retinal disorders","publication_year":2019,"publication_date":"2019-01-26","ids":{"openalex":"https://openalex.org/W2914138564","doi":"https://doi.org/10.1080/14712598.2019.1575358","mag":"2914138564","pmid":"https://pubmed.ncbi.nlm.nih.gov/30686077"},"language":"en","primary_location":{"id":"doi:10.1080/14712598.2019.1575358","doi":"https://doi.org/10.1080/14712598.2019.1575358","is_oa":false,"landing_page_url":"https://doi.org/10.1080/14712598.2019.1575358","pdf_url":null,"source":{"id":"https://openalex.org/S57380513","display_name":"Expert Opinion on Biological Therapy","issn_l":"1471-2598","issn":["1471-2598","1744-7682"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Biological Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2914138564"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075785252","display_name":"Enoch Kassa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Enoch Kassa","raw_affiliation_strings":["Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I4394709130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036246396","display_name":"Thomas A. Ciulla","orcid":"https://orcid.org/0000-0001-5557-6777","observed_orcids":["https://orcid.org/0000-0001-5557-6777"]},"institutions":[{"id":"https://openalex.org/I4210114778","display_name":"Midwest Eye Institute","ror":"https://ror.org/02ah36853","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114778"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas A. Ciulla","raw_affiliation_strings":["Retina Service, Midwest Eye Institute, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Retina Service, Midwest Eye Institute, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I4210114778"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013509468","display_name":"Rehan M. Hussain","orcid":"https://orcid.org/0000-0002-7008-4495","observed_orcids":["https://orcid.org/0000-0002-7008-4495"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rehan M. Hussain","raw_affiliation_strings":["Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026181496","display_name":"Pravin U. Dugel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I4210095183","display_name":"Retinal Consultants of Arizona","ror":"https://ror.org/00me1fb23","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210095183"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pravin U. Dugel","raw_affiliation_strings":["Retinal Consultants of Arizona, Phoenix, Arizona; USC Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA","Retinal Consultants of Arizona, Phoenix, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Retinal Consultants of Arizona, Phoenix, Arizona; USC Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I1174212","https://openalex.org/I4210095183"]},{"raw_affiliation_string":"Retinal Consultants of Arizona, Phoenix, Arizona","institution_ids":["https://openalex.org/I4210095183"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5013509468"],"corresponding_institution_ids":["https://openalex.org/I145608581"],"apc_list":null,"apc_paid":null,"fwci":3.0636,"has_fulltext":false,"cited_by_count":97,"citation_normalized_percentile":{"value":0.95177091,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"19","issue":"4","first_page":"335","last_page":"342"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9214000105857849,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9214000105857849,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.06909999996423721,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/complement-inhibition","display_name":"complement inhibition","score":0.9959999918937683},{"id":"https://openalex.org/keywords/dry-age-related-macular-degeneration","display_name":"dry age-related macular degeneration","score":0.9559999704360962},{"id":"https://openalex.org/keywords/stargardt-disease","display_name":"Stargardt disease","score":0.9980000257492065},{"id":"https://openalex.org/keywords/geographic-atrophy","display_name":"geographic atrophy","score":0.9860000014305115},{"id":"https://openalex.org/keywords/eculizumab","display_name":"eculizumab","score":0.9750000238418579},{"id":"https://openalex.org/keywords/properdin","display_name":"properdin","score":0.6850000023841858},{"id":"https://openalex.org/keywords/complement-factor-d","display_name":"complement factor D","score":0.6660000085830688},{"id":"https://openalex.org/keywords/gene-therapy","display_name":"gene therapy","score":0.7369999885559082},{"id":"https://openalex.org/keywords/intravitreal-injection","display_name":"intravitreal injection","score":0.6600000262260437}],"concepts":[{"id":"https://openalex.org/C2777991916","wikidata":"https://www.wikidata.org/wiki/Q421617","display_name":"Eculizumab","level":4,"score":0.8078658580780029},{"id":"https://openalex.org/C2776403814","wikidata":"https://www.wikidata.org/wiki/Q27429789","display_name":"Macular degeneration","level":2,"score":0.6741939783096313},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5913907289505005},{"id":"https://openalex.org/C111684460","wikidata":"https://www.wikidata.org/wiki/Q334848","display_name":"Complement system","level":3,"score":0.5186131000518799},{"id":"https://openalex.org/C2779931649","wikidata":"https://www.wikidata.org/wiki/Q416510","display_name":"C1-inhibitor","level":3,"score":0.4921695590019226},{"id":"https://openalex.org/C182629451","wikidata":"https://www.wikidata.org/wiki/Q18251054","display_name":"Complement factor B","level":4,"score":0.4872094988822937},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4606175124645233},{"id":"https://openalex.org/C189446657","wikidata":"https://www.wikidata.org/wiki/Q4736500","display_name":"Alternative complement pathway","level":4,"score":0.4459880590438843},{"id":"https://openalex.org/C179369057","wikidata":"https://www.wikidata.org/wiki/Q20970075","display_name":"Complement factor I","level":4,"score":0.42609792947769165},{"id":"https://openalex.org/C2780604041","wikidata":"https://www.wikidata.org/wiki/Q1317319","display_name":"Stargardt disease","level":3,"score":0.4190123975276947},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35200467705726624},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3098723292350769},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3098554015159607},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.18097758293151855},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.17791461944580078},{"id":"https://openalex.org/C2777995640","wikidata":"https://www.wikidata.org/wiki/Q1129007","display_name":"Angioedema","level":2,"score":0.08831587433815002}],"mesh":[{"descriptor_ui":"D000080362","descriptor_name":"Stargardt Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000080362","descriptor_name":"Stargardt Disease","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D000080362","descriptor_name":"Stargardt Disease","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003176","descriptor_name":"Complement C3","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D003182","descriptor_name":"Complement C5","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007140","descriptor_name":"Immunoglobulin Fab Fragments","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011416","descriptor_name":"Complement Factor D","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015316","descriptor_name":"Genetic Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057092","descriptor_name":"Geographic Atrophy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D057092","descriptor_name":"Geographic Atrophy","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D057092","descriptor_name":"Geographic Atrophy","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1080/14712598.2019.1575358","doi":"https://doi.org/10.1080/14712598.2019.1575358","is_oa":false,"landing_page_url":"https://doi.org/10.1080/14712598.2019.1575358","pdf_url":null,"source":{"id":"https://openalex.org/S57380513","display_name":"Expert Opinion on Biological Therapy","issn_l":"1471-2598","issn":["1471-2598","1744-7682"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Biological Therapy","raw_type":"journal-article"},{"id":"pmid:30686077","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30686077","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on biological therapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":63,"referenced_works":["https://openalex.org/W62535517","https://openalex.org/W154709760","https://openalex.org/W835771359","https://openalex.org/W1158091699","https://openalex.org/W1500728559","https://openalex.org/W1538904872","https://openalex.org/W1898328784","https://openalex.org/W1930918755","https://openalex.org/W1966318341","https://openalex.org/W1977327764","https://openalex.org/W1980724564","https://openalex.org/W1983873751","https://openalex.org/W1989558725","https://openalex.org/W1994172606","https://openalex.org/W2009256817","https://openalex.org/W2016520383","https://openalex.org/W2022258605","https://openalex.org/W2022658314","https://openalex.org/W2024215142","https://openalex.org/W2025010692","https://openalex.org/W2027707278","https://openalex.org/W2033621877","https://openalex.org/W2044529914","https://openalex.org/W2044627868","https://openalex.org/W2046761602","https://openalex.org/W2048618458","https://openalex.org/W2058378174","https://openalex.org/W2067554653","https://openalex.org/W2074035096","https://openalex.org/W2075861816","https://openalex.org/W2076961896","https://openalex.org/W2092638574","https://openalex.org/W2095317976","https://openalex.org/W2097013149","https://openalex.org/W2111078229","https://openalex.org/W2113784410","https://openalex.org/W2117386992","https://openalex.org/W2125820504","https://openalex.org/W2136963282","https://openalex.org/W2137331743","https://openalex.org/W2145027167","https://openalex.org/W2150201934","https://openalex.org/W2152506674","https://openalex.org/W2160226180","https://openalex.org/W2162838839","https://openalex.org/W2163193571","https://openalex.org/W2170341176","https://openalex.org/W2231512968","https://openalex.org/W2312259609","https://openalex.org/W2415663312","https://openalex.org/W2583232897","https://openalex.org/W2584917966","https://openalex.org/W2597405767","https://openalex.org/W2617433841","https://openalex.org/W2618137579","https://openalex.org/W2618542869","https://openalex.org/W2672043438","https://openalex.org/W2765837584","https://openalex.org/W2768174949","https://openalex.org/W2792435367","https://openalex.org/W2802822211","https://openalex.org/W2910907014","https://openalex.org/W2916032084"],"related_works":["https://openalex.org/W3190512093","https://openalex.org/W3168366002","https://openalex.org/W4412705481","https://openalex.org/W4385603117","https://openalex.org/W4380576694","https://openalex.org/W7220853237","https://openalex.org/W4386591840","https://openalex.org/W3174356873","https://openalex.org/W4416543574","https://openalex.org/W4386303913"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Dry":[1],"age-related":[2],"macular":[3],"degeneration":[4],"(AMD)":[5],"and":[6,22,111,117,124,134,158],"Stargardt":[7],"Macular":[8],"Dystrophy":[9],"(STGD1)":[10],"result":[11],"in":[12,54,72,96,127,143,168,175,193],"vision":[13],"loss":[14],"due":[15],"to":[16,36,48,68,79,92,139,189],"progressive":[17],"atrophy":[18,51],"of":[19,24,120,155,173],"the":[20,153,169,187],"macula":[21],"lack":[23],"effective":[25],"treatments.":[26],"Numerous":[27],"studies":[28],"have":[29],"implicated":[30],"complement-associated":[31],"inflammation":[32],"as":[33],"a":[34,73,97,194],"contributor":[35],"both":[37],"diseases.":[38],"AREAS":[39],"COVERED:":[40],"The":[41,58,83],"complement":[42,59,85,181],"factor":[43,60,86],"D":[44],"inhibitor,":[45,63,89,103],"lampalizumab,":[46],"failed":[47,91,138],"halt":[49,93,140,190],"geographic":[50],"(GA)":[52],"progression":[53,95,142,192],"phase":[55,74,80,98,128,144,148,170,195],"3":[56,61,81,196],"studies.":[57,146],"(C3)":[62],"APL-2,":[64],"has":[65,183],"shown":[66],"potential":[67],"reduce":[69],"GA":[70,94,141,191],"growth":[71],"2":[75,99,129,145],"trial,":[76,197],"supporting":[77],"advancement":[78],"trials.":[82,130],"intravenous":[84],"5":[87],"(C5)":[88],"eculizumab,":[90],"study.":[100],"Another":[101],"C5":[102],"avacincaptad":[104],"pegol,":[105],"is":[106,151,200],"delivered":[107],"by":[108,162],"intravitreal":[109],"injection,":[110],"will":[112,165],"be":[113,166],"studied":[114],"for":[115,122],"safety":[116],"preliminary":[118],"signs":[119],"efficacy":[121],"AMD":[123,176],"STGD1":[125],"patients":[126],"LFG316":[131,157],"(C5":[132],"inhibitor)":[133,137],"CLG561":[135],"(properdin":[136],"A":[147],"1":[149,171],"trial":[150,172],"evaluating":[152],"effects":[154],"combining":[156],"CL561.":[159],"Complement":[160],"inhibition":[161,182],"gene":[163],"therapy":[164],"explored":[167],"HMR59":[174],"patients.":[177],"EXPERT":[178],"OPINION:":[179],"While":[180],"not":[184],"yet":[185],"demonstrated":[186],"ability":[188],"further":[198],"study":[199],"warranted.":[201]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":16},{"year":2021,"cited_by_count":26},{"year":2020,"cited_by_count":21},{"year":2019,"cited_by_count":7}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2019-02-21T00:00:00"}
